-
Product Insights
Ischemia Reperfusion Injury – Drugs In Development, 2023
Global Markets Direct’s, ‘Ischemia Reperfusion Injury - Drugs In Development, 2023’, provides an overview of the Ischemia Reperfusion Injury pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ischemia Reperfusion Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Glomerulonephritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Glomerulonephritis - Drugs In Development, 2023’, provides an overview of the Glomerulonephritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Glomerulonephritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Acute Renal Failure (ARF) (Acute Kidney Injury) – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Renal Failure (ARF) (Acute Kidney Injury) - Drugs In Development, 2023’, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Simufilam Hydrochloride in Dementia Associated With Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Simufilam Hydrochloride in Dementia Associated With Alzheimer's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Simufilam Hydrochloride in Dementia Associated With Alzheimer's Disease...
-
Sector Analysis
Ethylene Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Feedstock, Projects and Forecast to 2030
Ethylene Capacity & CapEx Overview The ethylene capacity was 225.52 million tonnes per annum (mtpa) in 2022 and is poised to witness considerable growth of more than 46% from 2022 to 2030. Around 140 planned and announced plants are slated to come online by 2030, primarily in Asia and the Middle East. Ethylene Capacity and CapEx Outlook, 2022-2030 (mtpa) Buy the Full Report for More Insights on Ethylene Capacity and Capex Market Forecast Download a Free Report Sample The ethylene...
-
Sector Analysis
Propylene Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Feedstock, Projects and Forecast to 2030
Propylene Capacity & CapEx Overview Global propylene capacity was valued at 150.30 million tonnes per annum (mtpa) in 2022 and is poised to witness considerable growth of more than 46% from 2022 to 2030. Around 175 planned and announced plants are slated to come online by 2030, primarily in Asia and the Middle East with China and Iran being the top producers of Propylene globally. Propylene Capacity and CapEx Outlook, 2022-2030 (mtpa) Buy Full Report for More Insights on Propylene...
-
Company Profile
JUUL Labs Inc – Company Profile
JUUL Labs Inc (JUUL Labs) is an electronic cigarette company. Its products include JUULPod, Starter Kit, Slate JUUL, Silver JUUL, USB charging dock, portable charging case and other accessories. The company develops a temperature regulation system to heat the nicotine-based liquid to an ideal level which is designed to avoid burning. JUUL Labs offers men and women who serve the tools to succeed at using the alternative for adult smokers. The company markets its products through an online platform. JUUL...
Add to Basket -
Product Insights
LeCesse Dev Corp – Slate at Merrimack – New Hampshire
Equip yourself with the essential tools needed to make informed and profitable decisions with our LeCesse Dev Corp - Slate at Merrimack - New Hampshire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Sector Analysis
Methanol Capacity and Capital Expenditure Forecast by Region, Countries, Companies and Projects, 2023-2030
Methanol Capacity and Capital Expenditure Market Overview The Methanol capacity was 171.84mtpa in 2022. Around 123 planned and announced plants are slated to be online by 2030, primarily in the Former Soviet Union and the Middle East. FSU has 30 planned and announced plants, of which Russia has 22. In Middle East, the majority of capacity additions are in Iran. Methanol Capacity Market Outlook, 2022-2030 (mtpa) For more insights into the Methanol capacity and capex market forecast, download a free...